Key Details
Price
$1.38Annual ROE
-48.93%Beta
1.29Events Calendar
Next earnings date:
Apr 4, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Apr 4, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Apr 5, 24 Piper Sandler
NeutralApr 5, 24 Chardan Capital
BuyDec 14, 23 B of A Securities
UnderperformAug 7, 23 Chardan Capital
BuyMay 11, 23 Chardan Capital
BuyDec 7, 22 Piper Sandler
OverweightDec 7, 22 Chardan Capital
BuyApr 26, 21 Piper Sandler
OverweightApr 26, 21 Oppenheimer
OutperformApr 26, 21 JP Morgan
UnderweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Achilles Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
ACHL
globenewswire.comNovember 14, 2024
– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 –
Achilles Therapeutics to Present at Upcoming Conferences
ACHL
GlobeNewsWireJune 12, 2023
LONDON, June 12, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the following conferences in June:
3 Stocks With 1,000% Upside Potential
ACHL
InvestorPlaceMay 21, 2023
If you're a risk taker on the lookout for stocks with 1000% upside potential, you'd have to venture into speculative territory. It is difficult to find analyst ratings with such a high upside potential unless catalysts could propel the stock that high.
FAQ
- What is the ticker symbol for Achilles Therapeutics?
- Does Achilles Therapeutics pay dividends?
- What sector is Achilles Therapeutics in?
- What industry is Achilles Therapeutics in?
- What country is Achilles Therapeutics based in?
- When did Achilles Therapeutics go public?
- Is Achilles Therapeutics in the S&P 500?
- Is Achilles Therapeutics in the NASDAQ 100?
- Is Achilles Therapeutics in the Dow Jones?
- When was Achilles Therapeutics's last earnings report?
- When does Achilles Therapeutics report earnings?
- Should I buy Achilles Therapeutics stock now?
What is the ticker symbol for Achilles Therapeutics?
The ticker symbol for Achilles Therapeutics is NASDAQ:ACHL
Does Achilles Therapeutics pay dividends?
No, Achilles Therapeutics does not pay dividends
What sector is Achilles Therapeutics in?
Achilles Therapeutics is in the Healthcare sector
What industry is Achilles Therapeutics in?
Achilles Therapeutics is in the Biotechnology industry
What country is Achilles Therapeutics based in?
Achilles Therapeutics is headquartered in United Kingdom
When did Achilles Therapeutics go public?
Achilles Therapeutics's initial public offering (IPO) was on March 31, 2021
Is Achilles Therapeutics in the S&P 500?
No, Achilles Therapeutics is not included in the S&P 500 index
Is Achilles Therapeutics in the NASDAQ 100?
No, Achilles Therapeutics is not included in the NASDAQ 100 index
Is Achilles Therapeutics in the Dow Jones?
No, Achilles Therapeutics is not included in the Dow Jones index
When was Achilles Therapeutics's last earnings report?
Achilles Therapeutics's most recent earnings report was on Nov 14, 2024
When does Achilles Therapeutics report earnings?
The next expected earnings date for Achilles Therapeutics is Apr 4, 2025
Should I buy Achilles Therapeutics stock now?
As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions